12.51

0.48% 0.06

Astria Therapeutics Inc (ATXS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$12.45

Aprire:

$12.43

Volume 24 ore:

651.00K

Relative Volume:

0.39

Capitalizzazione di mercato:

$714.13M

Reddito:

Utile/perdita netta:

$-72.89M

Rapporto P/E:

-5.1694

EPS:

-2.42

Flusso di cassa netto:

$-68.47M

1 W Prestazione:

-0.48%

1M Prestazione:

+2.88%

6M Prestazione:

+219.13%

1 anno Prestazione:

+33.94%

Intervallo 1D:

$12.40

$12.57

Intervallo di 1 settimana:

$12.31

$12.62

Portata 52W:

$3.555

$12.71

Astria Therapeutics Inc Stock (ATXS) Company Profile

Nome

Astria Therapeutics Inc

Settore

Healthcare (1129)

Industria

Biotechnology (632)

Telefono

617-349-1971

Indirizzo

22 BOSTON WHARF ROAD, BOSTON

Dipendente

Cinguettio

Prossima data di guadagno

2025-03-11

Ultimi documenti SEC

ATXS's Discussions on Twitter

Confronta ATXS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATXS Astria Therapeutics Inc	12.51	710.71M	0	-72.89M	-68.47M	-2.42
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-12	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-09-17	Reiterato	H.C. Wainwright	Buy
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-01-31	Iniziato	JMP Securities	Mkt Outperform
2024-07-29	Iniziato	TD Cowen	Buy
2023-03-28	Iniziato	Evercore ISI	Outperform

Mostra tutto

Astria Therapeutics Inc Borsa (ATXS) Ultime notizie

Nov 22, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN - The Malaysian Reserve

Nov 22, 2025

Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Nov 22, 2025

Nov 21, 2025

(ATXS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Nov 21, 2025

Nov 20, 2025

Will Astria Therapeutics Inc. stock split again soonJuly 2025 Summary & High Yield Equity Trading Tips - newser.com

Nov 20, 2025

How Astria Therapeutics Inc. stock performs in interest rate cycles2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com

Nov 20, 2025

Will Astria Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Review & Weekly High Potential Alerts - newser.com

Nov 20, 2025

Can Astria Therapeutics Inc. stock deliver surprise earnings beatWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com

Nov 20, 2025

Nov 19, 2025

Can Astria Therapeutics Inc. stock outperform in 2025 bull marketPortfolio Return Summary & Detailed Earnings Play Alerts - newser.com

Nov 19, 2025

Combining price and volume data for Astria Therapeutics Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com

Nov 19, 2025

Nov 18, 2025

Why Astria Therapeutics Inc. is moving todayJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com

Nov 18, 2025

Is this a good reentry point in Astria Therapeutics Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com

Nov 18, 2025

Will Astria Therapeutics Inc. stock deliver shareholder valueEarnings Risk Report & AI Driven Stock Reports - newser.com

Nov 18, 2025

Nov 17, 2025

Is Astria Therapeutics Inc. stock a contrarian buyJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com

Nov 17, 2025

Nov 16, 2025

Is Astria Therapeutics Inc. stock overvalued by current metrics2025 Price Action Summary & High Return Trade Guides - newser.com

Nov 16, 2025